查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197304

充氣設備市場——增長、趨勢、COVID-19 的影響和預測 (2023-2028)

Insufflation Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 117 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

充氣設備市場預計在預測期內（2022 年至 2027 年）的複合年增長率為 6.3%。

COVID-19 疫情和相關法規正在改變全球醫療保健系統的運作方式。 持續的“冠狀病毒病 19”(COVID-19) 大流行正在對世界各地的外科護理服務產生重大影響。 擇期手術正在推遲，以便為 COVID-19 患者提供更多資源。 根據 2021 年 7 月發表的題為“COVID-19 大流行對減肥手術患者決策的影響”的研究論文，“COVID-19 大流行影響了患者對減肥手術的決策。減肥手術在國際肥胖和代謝外科醫生聯合會 (IFSO) 發佈建議後，大多數國家都撤回了這一建議。 在全球範圍內，每月大約有 60,000 例減肥手術被推遲。 幾個月後，一些政府開始放寬限制，重新開放企業和公共場所，允許社交互動，並允許恢復擇期手術。 因此，COVID-19 在大流行開始時對充氣設備市場產生了重大影響。

由於手術技術的發展，手術數量的增加，以及全世界子宮肌瘤、肥胖、心髒病等的增加，對絕緣裝置的需求越來越大。 市場增長的一個主要驅動力是由於久坐不動的生活方式和攝入高脂肪和高糖的能量密集型飲食導致的肥胖症增加。 據美國健康信託基金會預測，2020 年美國成人肥胖率將達到 42.4%，全國首次超過 40%。

由於在減肥手術中使用充氣裝置，BMI 為 35-39 且患有某些主要健康問題（例如 2 型糖尿病、睡眠呼吸暫停和高血壓）的肥胖人群的增加趨勢正在推動市場。是一個強大的驅動力的 根據世界衛生組織 2021 年 6 月的數據，2020 年有 3900 萬五歲以下兒童超重或肥胖。 此外，世界肥胖聯盟發布的 2022 年 3 月世界肥胖地圖預測，到 2030 年，全球將有 10 億人肥胖，其中包括五分之一的女性和七分之一的男性。我來了。 此外，減肥手術的實用性已得到普遍認可，增加了對充氣裝置作為治療選擇的需求。

充氣裝置市場趨勢

腹腔鏡手術部門有望佔據充氣裝置市場的主要份額

預計腹腔鏡手術領域在預測期內將顯著增長腹腔鏡手術由於其優勢，預計將在世界範圍內進行的手術數量增加，因此，抽吸裝置有望增加. 根據克利夫蘭診所 2022 年的數據，全世界每年大約進行 1300 萬例腹腔鏡手術。 未來五年，這一數字預計將增長 1%。 腹腔鏡手術廣泛用於高危患者，例如老年人、肥胖者以及患有心血管或肺部疾病等既往疾病的患者。 根據美國疾病控制與預防中心 (CDC) 2020 年的數據，美國每年進行超過 60 萬例子宮切除術，估計美國約有 2000 萬女性接受過子宮切除術。 針對這種情況，預計對絕緣設備的需求將會增加。

該領域受到全球越來越多地使用腹腔鏡手術的推動，包括腹腔鏡膽囊切除術、疝修補術、腹腔鏡脾切除術和肝切除術。. 腹腔鏡手術具有術後疼痛減輕、美容效果好、患者滿意度提高、住院時間短等優點。 緊急腹腔鏡手術的數量也在增加。 由於腹腔鏡手術中普遍使用充氣裝置，預計這些因素將推動市場向前發展並促進市場增長。

預計北美將佔據很大的市場份額，並且很可能在預測期內佔據這一份額。

肥胖正迅速成為一個主要的公共衛生問題。 通過直接和間接支出，肥胖對經濟的影響與其流行程度同步增長。 COVID-19 流行病正在造成越來越容易肥胖的氣候，同時對肥胖產生不利影響，並減少獲得肥胖治療和治療肥胖相關疾病的機會。

由於發達的醫療保健基礎設施、對創新技術解決方案的需求不斷增長以及大量行業領先參與者的存在，北美市場正在崛起。 對微創手術的需求不斷增長也有望推動市場增長。 在微創腹部手術（例如膽囊切除術）期間，需要進入以允許將工具插入腹部。

技術進步也有助於推動北美市場向前發展。 例如，Stryker 的 45L Pneumosure XL Insufflator 提供了令人印象深刻的性能並提高了安全性和可靠性。 包括兩種額外的模式：減肥和血管收穫。 這種氣腹還包括一個實時壓力傳感器，提高了手術的準確性，但這個功能需要專用的氣腹管。 除了在最苛刻的條件下保持氣腹外，Pneumosure 還憑藉其完全集成的彩色觸摸屏在世界各地的任何手術室中都易於使用。 2021 年 7 月，Pariale 的 END-200 管組獲得了 FDA 510(k)許可，這將 EVA15 連續壓力氣腹技術的能力從腹腔鏡手術擴展到內窺鏡-內窺鏡手術。 因此，上述所有因素預計將推動市場的增長。

充氣設備市場競爭對手分析

充氣裝置市場分散且競爭激烈，由幾家大型企業組成。 市場上的一些參與者包括 STERIS、COMEG、Stryker、B. Braun Medical Ltd、CONMED Corporation、Karl Storz、Olympus、Koninklijke Philips N.V.、Bracko Diagnostics Inc、Meditech Systems Ltd、Medtronic、FUJIFILM Holdings America Corporation。、Smith & 侄子和理查德沃爾夫。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 全球腹腔鏡手術的普及率不斷上升
    • 技術進步
  • 市場製約因素
    • 與充氣相關的並發症
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 通過申請
    • 腹腔鏡手術
    • 內窺鏡手術
    • 其他
  • 最終用戶
    • 醫院
    • 診所
    • 門診手術中心
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • STERIS
    • COMEG
    • Stryker
    • B. Braun Medical Ltd
    • CONMED Corporation
    • Karl Storz
    • Olympus
    • Koninklijke Philips N.V.
    • Bracco Diagnostics Inc.
    • Baptist Health
    • Medtronic
    • FUJIFILM Holdings America Corporation
    • Smith & Nephew
    • Richard Wolf

第7章 市場機會今後動向

簡介目錄
Product Code: 90582

The insufflation devices market is projected to register a CAGR of 6.3% during the forecast period (2022-2027).

The COVID-19 epidemic and the resulting restrictions have altered how healthcare systems operate worldwide. The continuing "coronavirus disease 19" (COVID-19) pandemic has had a significant impact on surgical care delivery around the world. Elective operations have been postponed to devote more resources to COVID-19 patients. According to a research article published in July 2021 titled "Impact of the COVID-19 Pandemic on the Patient's Decision about Bariatric Surgery: Results of a National Survey," bariatric operations were withdrawn in most countries after the International Federation for the Surgery of Obesity, and Metabolic Disorders issued recommendations (IFSO). Approximately 60,000 bariatric procedures per month may have been postponed globally. After a few months, several governments have begun to ease restrictions, such as reopening businesses and public areas, permitting social interaction, and allowing elective surgery to resume. As a result, COVID-19 significantly impacted the market for insufflation devices at the start of the pandemic.

Due to technological developments in surgery, an increase in the number of surgical cases, and an increase in the frequency of uterine fibroids, obesity, and cardiac diseases around the world, the need for insufflation devices is rising. One of the major factors driving market expansion is the rising incidence of obesity due to a sedentary lifestyle and an increase in the consumption of energy-dense meals high in fat and sugar. According to the Trust for America's Health, the adult obesity rate in the United States reached 42.4 percent in 2020, marking the first time the national percentage exceeded 40%.

As insufflation devices are used in bariatric surgery, the rising prevalence of obese persons with a BMI of 35-39 who have certain major health concerns, such as type 2 diabetes, sleep apnea, and high blood pressure, is a high-impact driver of the market. According to the World Health Organization in June 2021, there were 39 million under-five years old kids who were overweight or obese in 2020. Moreover, World Obesity Atlas March 2022 published by the World Obesity Federation, predicts that by 2030, one billion people worldwide, including one in five women and one in seven men, will have obesity. Furthermore, as the public becomes more aware of the benefits of bariatric surgery, the demand for insufflation devices as a treatment option has grown.

Insufflation Devices Market Trends

The Laparoscopic Surgery Segment is Expected to Hold a Major Market Share in the Insufflation Devices Market

The laparoscopic surgery segment is projected to grow significantly over the forecast period. Insufflation devices are predicted to rise as the number of laparoscopic procedures conducted worldwide increases due to their benefits. Every year, about 13 million laparoscopic surgeries are performed worldwide, according to the Cleveland Clinic 2022. Over the next five years, these figures are expected to rise by 1%. Laparoscopic surgery is widely used in high-risk patients, such as the elderly, obese patients, and those with preexisting illnesses such as cardiovascular and pulmonary problems. According to the Center for Disease Control and Prevention (CDC) 2020, over 600,000 hysterectomies are performed in the United States each year, and approximately 20 million women in the United States have undergone a hysterectomy. Insufflation devices are projected to be in more demand due to such occurrences.

The segment is being driven by an increase in the use of laparoscopic surgical methods such as laparoscopic cholecystectomy, hernia repair, laparoscopic splenectomy, and hepatectomy worldwide. A few advantages of laparoscopic surgery are a few advantages of reduced postoperative pain, superior cosmetic results, increased patient satisfaction, and a shorter hospital stay. There has also been an increase in the number of laparoscopic emergency operations. Because insufflation devices are commonly employed in laparoscopic procedures, such factors are projected to propel the market forward, thereby boosting the market growth.

North America is Expected to Hold a significant share in the market and is expected to do the Same in the Forecast Period.

Obesity has quickly become a major public health concern. Obesity's economic impact grows in lockstep with its prevalence, owing to both direct and indirect expenditures. The COVID-19 pandemic has negatively influenced obesity, lowering access to bariatric care and treatment of obesity-related disorders while also generating an increasingly obesogenic atmosphere.

North America's market is rising due to its developed healthcare infrastructure, growing demand for innovative technical solutions, and the considerable presence of leading industry participants. In addition, the region's growing desire for less invasive surgeries is expected to enhance the market growth. Access is necessary to allow tools to be inserted into the abdomen during a minimally invasive surgical procedure in the abdomen, such as gallbladder removal.

Technological advances are also helping to drive the market in North America forward. For example, Stryker's 45L PneumoSure XL insufflator offers remarkable performance and improved safety and reliability. Bariatrics and Vessel Harvesting are two additional modes included. This insufflator also includes real-time pressure sensing for improved precision during procedures, but this feature requires special insufflation tubing. The ability of the PneumoSure to maintain pneumoperitoneum under the most extreme situations, along with a fully integrated color touch screen, makes it easier to use in any operating room worldwide. In July 2021, Palliare received FDA 510(k) clearance for its END-200 tubeset, which extends the capabilities of its EVA15 continuous pressure insufflation technology from laparoscopic surgery to endoscopic and endoluminal surgery. Hence, all the abovementioned factors are projected to boost the market's growth.

Insufflation Devices Market Competitor Analysis

The insufflation device market is fragmented and competitive and consists of several major players. Some players operating in the market are STERIS, COMEG, Stryker, B. Braun Medical Ltd, CONMED Corporation, Karl Storz, Olympus, Koninklijke Philips N.V., Bracco Diagnostics Inc., Meditech Systems Ltd, Medtronic, FUJIFILM Holdings America Corporation, Smith & Nephew, and Richard Wolf.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Global Increase in the Prevalence of Laparoscopic Procedures
    • 4.2.2 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 Gas insufflation-related complications
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Application
    • 5.1.1 Laproscopic Surgery
    • 5.1.2 Endoscopic Surgery
    • 5.1.3 Others
  • 5.2 By End Use
    • 5.2.1 Hospitals
    • 5.2.2 Clinics
    • 5.2.3 Ambulatory Surgical Center
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 STERIS
    • 6.1.2 COMEG
    • 6.1.3 Stryker
    • 6.1.4 B. Braun Medical Ltd
    • 6.1.5 CONMED Corporation
    • 6.1.6 Karl Storz
    • 6.1.7 Olympus
    • 6.1.8 Koninklijke Philips N.V.
    • 6.1.9 Bracco Diagnostics Inc.
    • 6.1.10 Baptist Health
    • 6.1.11 Medtronic
    • 6.1.12 FUJIFILM Holdings America Corporation
    • 6.1.13 Smith & Nephew
    • 6.1.14 Richard Wolf

7 MARKET OPPORTUNITIES AND FUTURE TRENDS